Frazier Healthcare Partners Closes $1.4 Billion Growth Buyout Fund

Frazier Healthcare Partners has announced it has closed its 10th private equity fund focused exclusively on the healthcare middle market.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Frazier Healthcare Partners has announced it has closed its 10th private equity fund focused exclusively on the healthcare middle market.

The oversubscribed fund — Frazier Healthcare Growth Buyout Fund X — hit its hard cap of $1.4 billion in capital commitments.

With the addition of new fund, Frazier Healthcare Partners has now raised more than $6.2 billion total capital.

Frazier Healthcare Partners, based in Seattle, is a provider of private equity capital to healthcare companies. The firm, founded in 1991, prefers to make more substantial investments from a dollars perspective and pursues a wide range of investment types, including company creation and venture capital to buyouts of profitable lower-middle market companies.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Frazier Healthcare Partners Closes $1.4 Billion Growth Buyout Fund

United States Food, Drugs, Healthcare, Life Sciences

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More